We then investigated SLC16A13’s impact on the BPIV-3a replication cycle: measuring viral titers at multiple time points post-infection (MOI 0.1) showed that SLC16A13 KO affected the late stage of BPIV-3a replication (Figure 4(F)). Here, SLC16A13 is linked to infection.